NRG GU007

Primary Category:

Radiation Oncology

Disease Category:

Genitourinary, Prostate

Status:

Open, Temporarily Closed

Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I)

 

NCT#04037254

GU007 is temporarily closed effective 09/16/20, for a protocol-specified toxicity analysis.